Zobrazeno 1 - 10
of 36
pro vyhledávání: '"F Arizio"'
Autor:
F. Arizio, Celeste Cagnazzo, Giuseppe Procopio, Oriana Nanni, Rosita Cenna, V. Franchina, Nicla La Verde, Stefania Gori, Vincenzo Adamo, Alessandro Di Costanzo, Fabrizio Nicolis, Angela Maria Elena Frazzetto
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:433-440
Background: New trends are emerging in clinical research, such as patient empowerment and an active role in influencing health and research ethics. Patients’ involvement is considered pivotal by st...
Autor:
F. Passiglia, L. Righi, A. Listì, F. Tabbò, P. Bironzo, M.L. Reale, C. Sini, S. Vallone, F. Arizio, M.V. Pacchiana Parravicini, L. Mazilu, H. Linardou, E. Roca, L. Buffoni, K. Mohorcic, V. Barbieri, D. Pignataro, A. Araujo, L. Paz Ares, E. Felip, N. Secen, A. Comanescu, E. Szmytke, G. Scagliotti, S. Novello
Publikováno v:
Journal of Thoracic Oncology. 17:S590
Autor:
E. Felip, L. Mazilu, Helena Linardou, A. Comanescu, Claudio Sini, F. Arizio, G.V. Scagliotti, Luis Paz-Ares, N.M. Secen, S. Vallone, A. Araújo, Francesco Passiglia, Paolo Bironzo, Luisella Righi, Angela Listì, Silvia Novello, E. Szmytke, Maria Lucia Reale, Fabrizio Tabbò, K. Mohorcic
Publikováno v:
Annals of Oncology. 32:S1037-S1038
Autor:
F. Arizio, Pamela Pizzutilo, Annapaola Mariniello, Michele Montrone, Domenico Galetta, Giuseppe Migliaretti, Silvia Genestroni, Fabrizio Tabbò, A. Alemanni, Hector Soto Parra, Gloria Borra, Tiziana Vavalà, Roberta Buosi, Simona Carnio, Alice Lunghi, Silvia Novello, Annamaria Catino, Ilaria Stura, Gianmauro Numico
Publikováno v:
Journal of Molecular Pathology
Volume 1
Issue 1
Pages 4-31
Volume 1
Issue 1
Pages 4-31
Background: Neutrophil-to-Lymphocyte Ratio (NLR) and derived Neutrophils-to-(Leukocytes minus neutrophils) Ratio (dNLR) have been proposed as possible biomarkers of response to immune checkpoint inhibitors (ICI). However, in non-small cell lung cance
Autor:
Silvia Novello, Luisella Righi, Angela Listì, F. Arizio, Paolo Bironzo, Marco Volante, Giorgio V. Scagliotti, Francesco Passiglia
Treatment with poly ADP ribose polymerase (PARP)1/2 inhibitors represents a novel opportunity to selectively kill a subset of cancer cell types by exploiting their deficiencies in DNA repair, thus leading to synthetic lethality. Treatment of homologo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15a483c9acccc7f75e05ac567d363d09
http://hdl.handle.net/2318/1762574
http://hdl.handle.net/2318/1762574
Autor:
Monika Serke, Gunther H. Wiest, H. Sotoparra, E. Stoelben, Antonio Santo, G. Valmadre, I. Colantonio, F. Arizio, Alessandra Bearz, Christian Manegold, Alessandro Morabito, Frank Griesinger, G.V. Scagliotti, A. Ferrari, W. Schütte, Luca Porcu, Luisella Righi, Vanesa Gregorc, Michael Geissler, Martin Reck, Silvia Novello, Nicolas Dickgreber, M. Schena, Orazio Caffo, Valentina Monica, Mario Spatafora, F.L. Cecere, Christian Grohé, Valter Torri, G. Borra, Christian Schumann, Alessandro Follador, Rita Chiari, Luciana Irtelli, A. Meyer
Publikováno v:
Journal of Thoracic Oncology. 16:S58-S59
Autor:
Vieri Scotti, Salvatore Pisconti, Paolo Graziano, Evaristo Maiello, Ferdinando Riccardi, F. Arizio, Emilio Bria, Domenico Galetta, Giulio Rossi, Marcello Tiseo, Diego Cortinovis, Silvia Novello, Lucio Buffoni, Anna Ceribelli, Tindara Franchina, Maria Rita Migliorino, Angelo Delmonte, Elisa Gobbini, Paola Bordi, Vanesa Gregorc, Massimo Di Maio, Annamaria Catino, Antonio Rossi
Publikováno v:
Lung Cancer. 111:30-37
Objectives Molecular profiling of advanced non-small-cell lung cancer (NSCLC) is recommended according to European and Italian guidelines. However, molecular routine assessment remains still heterogeneous. This observational study aimed to take a pic
Autor:
F. Arizio, Francesca Vannini, Alessandro Di Costanzo, Rosita Cenna, Gianna Tabaro, Giuseppe Procopio, Veronica Franchina, Stefania Gori, Celeste Cagnazzo, Oriana Nanni
Publikováno v:
Tumori. 106(4)
Background: The Agenzia Italiana del Farmaco (AIFA) Determination 809/2015 sets all the requirements that clinical units and laboratories must meet in order to conduct phase I studies. Requirements include buildings, equipment, personnel, emergency m
Autor:
Silvia Novello, Massimo Di Maio, Massimo Aglietta, Teresa Severina Di Stefano, Elisa Gobbini, F. Arizio, Roberta Matocci, Rita Chiari, P. Petrillo, Alessandro Di Costanzo, Valentina Polo, Isabella Sperduti, Sara Pilotto, Celeste Cagnazzo, Emilio Bria, Domenico Galetta, Giulia Pasello
Introduction Contract research organization (CRO) support is largely included in clinical trial management, although its effect in terms of time savings and benefit has not yet been quantified. We performed a retrospective multicenter analysis of lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984a32735396930c0c38828f2015f8b7
http://hdl.handle.net/11577/3367861
http://hdl.handle.net/11577/3367861
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(7)
Background In July 2012, the European Commission formalized the proposal for a European Clinical Trial Regulation that should replace the European Clinical Trials Directive 2001/20/CE. The new Regulation 536/2014 entered into force in June 2014 and i